Can treating parents help teens with anxiety?
NCT ID NCT07219992
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a parent-only therapy (SPACE) can reduce anxiety in teens, compared to a parent education support group. About 108 adolescents with anxiety disorders will participate. Parents attend 12 weekly sessions, and researchers measure teen anxiety symptoms before, after, and at follow-up.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Parent-based behavioral therapy (SPACE) and parent education support (PES)
- What this could lead to
- If it works, this could offer an effective, parent-only treatment option for adolescent anxiety disorders, reducing the need for direct teen therapy.
- What could go wrong
- This is a relatively small, early-stage trial (108 participants) comparing two active interventions, so it may not show a clear advantage for SPACE. Results may not generalize to all teens or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 108 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Nov 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
14 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Meet criteria for a primary DSM-5 AD, including separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, and agoraphobia (determined by the ADIS-C/P). * Cease all other psychosocial treatment, upon consultation with the project staff and service provider. * Not currently use any psychotropic medication, other than a stable dose (i.e., same dose for a minimum of 6 months prior to enrollment; no changes during course of the study) of a stimulant medication or selective serotonin reuptake inhibitor (SSRI). * Have an eligible and willing participating parent (see parent exclusions below). Exclusion Criteria: Adolescent: * Meet criteria for any DSM-5 disorder more impairing than the most impairing AD (determined by the ADIS-C/P). * Have any of the following disorders: autism spectrum disorder; intellectual disability; neurocognitive disorders; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders (determined by the Health History Form and ADIS-C/P). * Report a suicide attempt in the last 3 months, or current suicide intent and plans (determined by the ASQ). * Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services. * Not have sufficient proficiency with the English language to complete assessments. Parents: * Have any of the following: intellectual disability; neurocognitive disorders; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders (determined by the Health History Form). * Not be living with the adolescent at least 50% of the time for at least one year prior to enrollment. * Not have sufficient proficiency with the English language to complete assessments and treatment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Agoraphobia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Yale Child Study Center
RECRUITINGNew Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cannabis tincture quiet an anxious mind?
- Can a computer game rewire anxious Kids' brains?
- Can a phone app help people face cockroach fears from home?
- Can a new Under-the-Tongue drug offer lasting relief for Treatment-Resistant anxiety?
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Can a smartphone app calm anxiety and protect the heart?